Followers | 145 |
Posts | 27566 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Wednesday, October 11, 2017 3:21:34 PM
Oct. 11, 2017 3:03 PM ET|About: Kitov Pharmaceuticals ... (KTOV)|By: Douglas W. House, SA News Editor
Thinly traded nano cap Kitov Pharmaceuticals Holdings (KTOV +36.6%) joins the ever-growing list of biotech breakouts on more than an 18x surge in volume. No particular news accounts for the action.
Last week the company announced an additional 27% stake in TyrNovo with promising cancer candidate NT219 and the submission of its U.S. marketing application for combo med KIT-302.
Previously: Kitov ups stake in oncology-focused TyrNovo to 92%; shares ahead 9% premarket (Oct. 6)
Previously: Kitov files U.S. marketing application for lead candidate KIT-302; shares ahead 8% premarket (Oct. 2)
https://seekingalpha.com/news/3300500-kitov-pharma-latest-biotech-breakout-shares-37-percent?app=1&uprof=45&dr=1#email_link
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM